+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Healthcare CMO Market, By Service, By Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

  • PDF Icon

    Report

  • 182 Pages
  • September 2021
  • Region: Global
  • Coherent Market Insights Pvt Ltd.
  • ID: 5456000
A contract manufacturing organization, also known as a contract manufacturing and development organization, is an organization that serves pharmaceutical companies on a contract basis to offer comprehensive services from invention through commercialization to provide pharmaceuticals for healthcare. The primary function of these organizations is to provide the pharmaceutical and biotechnology industries with products that are designed, developed and manufactured under contract. Contract manufacturers usually build their business in close association with the pharmaceutical and bio-tech groups. As a result of this close relationship, these organizations can offer the same quality and quantity of products that would be available through the licensed facility. There are a number of advantages to contract manufacturing from a contract manufacturer.



Market Dynamics:


Increasing investment in R&D of drugs is expected to propel growth of the global healthcare CMO market over the forecast period. For instance, in September 2021, Aragen Life Sciences announced its plans to invest in expanding infrastructure in Hyderabad and Bengaluru (India) for drug discovery, and building a new facility in the U.S to manufacture biologics. Similarly, in August 2021, Curia announced plans to expand its commercial manufacturing capacity at its Rensselaer, NY facility.

Key features of the study:

  • This report provides in-depth analysis of the global healthcare CMO market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global healthcare CMO market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Accellent, Inc., Boehringer Ingelheim GmbH, Catalent Pharma Solutions, Inc., DSM, Fareva, Greatbatch, Inc., Lonza Group, Patheon, Inc. (Thermo Fisher Scientific Inc.), Piramal Healthcare, Binex, Cytovance Biologics, Emergent BioSolutions Inc., MilliporeSigma, Symbiosis Pharmaceutical Services, Albany Molecular Research Inc., Samsung Biologics, and Symmetry Medical, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global healthcare CMO market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global healthcare CMO market

Detailed Segmentation:


Global Healthcare CMO Market , By Service:

  • Pharmaceutical Contract Manufacturing Services
  • Medical Device Contract Manufacturing Services

Global Healthcare CMO Market, By Region:

  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • North Africa
  • Central Africa
  • South Africa

Company Profiles

  • Accellent, Inc.*
  • Company Highlights
  • Products Portfolio
  • Key Highlights
  • Financial Performance
  • Strategy
  • Boehringer Ingelheim GmbH
  • Catalent Pharma Solutions, Inc.
  • DSM
  • Fareva
  • Greatbatch, Inc.
  • Lonza Group
  • Patheon, Inc. (Thermo Fisher Scientific Inc.)
  • Piramal Healthcare
  • Binex
  • Cytovance Biologics
  • Emergent BioSolutions Inc.
  • MilliporeSigma
  • Symbiosis Pharmaceutical Services
  • Albany Molecular Research Inc.
  • Samsung Biologics
Frequently Asked Questions about the Healthcare CMO Market

What is the estimated value of the Healthcare CMO Market?

The Healthcare CMO Market was estimated to be valued at $326.8 Million in 2021.

What is the growth rate of the Healthcare CMO Market?

The growth rate of the Healthcare CMO Market is 16.1%, with an estimated value of $928.8 Million by 2028.

What is the forecasted size of the Healthcare CMO Market?

The Healthcare CMO Market is estimated to be worth $928.8 Million by 2028.

Who are the key companies in the Healthcare CMO Market?

Key companies in the Healthcare CMO Market include Accellent Inc., Boehringer Ingelheim GmbH, Catalent Pharma Solutions Inc., DSM, Fareva, Greatbatch Inc., Lonza Group, Patheon Inc. (Thermo Fisher Scientific Inc.) and Binex.

Table of Contents

1. Research Objective and Assumption
  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview
  • Report Description
  • Market Definition and Scope
  • Executive Summary
  • Market Snippet, By Service
  • Market Snippet, By End User
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
  • Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
  • Impact Analysis
  • Key Developments
  • Technological Advancement
  • Regulatory Scenario
  • Pipeline Analysis

4. Global Healthcare CMO Market, By Service, 2017 - 2028 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018-2028
  • Segment Trends
  • Pharmaceutical Contract Manufacturing Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends
  • Medical Device Contract Manufacturing Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
  • Segment Trends

5. Global Healthcare CMO Market, By Region, 2017 - 2028 (US$ Mn)
  • Introduction
  • Market Share Analysis, 2021 and 2028 (%)
  • Y-o-Y Growth Analysis, 2018-2028
  • Regional Trends
  • North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
  • U.S.
  • Canada
  • Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Service, 2017 - 2028, (US$ Mn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2028, (US$ Mn)
  • North Africa
  • Central Africa
  • South Africa

6. Competitive Landscape
  • Company Profiles
  • Accellent, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Boehringer Ingelheim GmbH
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Catalent Pharma Solutions, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • DSM
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Fareva, Greatbatch, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Lonza Group
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Patheon, Inc. (Thermo Fisher Scientific Inc.)
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Piramal Healthcare
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Binex
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Cytovance Biologics
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Emergent BioSolutions Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • MilliporeSigma
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Symbiosis Pharmaceutical Services
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Albany Molecular Research Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Samsung Biologics
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
  • Symmetry Medical, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

7. Section
  • References
  • Research Methodology
  • About us and Sales Contact

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Accellent Inc.
  • Boehringer Ingelheim GmbH
  • Catalent Pharma Solutions Inc.
  • DSM
  • Fareva
  • Greatbatch Inc.
  • Lonza Group
  • Patheon Inc. (Thermo Fisher Scientific Inc.)
  • Piramal Healthcare
  • Binex
  • Cytovance Biologics
  • Emergent BioSolutions Inc.
  • MilliporeSigma
  • Symbiosis Pharmaceutical Services
  • Albany Molecular Research Inc.
  • Samsung Biologics